Genmab reports DARZALEX net sales of $3.67 billion in Q3 2025

Go back to Genmab reports DARZALEX net sales of $3.67 billion in Q3 2025
(NASDAQ: GMAB) Delayed: 33.93 -0.48 (1.39%)
Previous Close $34.41    52 Week High
Open $33.96    52 Week Low
Day High $34.19    P/E N/A 
Day Low $33.74    EPS
Volume 124,702